Minimum Data Set (MDS) Development
During the year, the Minimum Data Set Working group (MDSWG) has met several times to review possible changes to the data we collect.
Suggested changes were submitted by a range of NJR stakeholders, including orthopaedic specialist societies, implant manufacturing industry, NJR delivery contractors and surgeons.
Changes were considered against the following criteria:
a. The need to keep the MDS up-to-date and to reflect changes in clinical practice.
b. The effect of changes on the structure of the database maintained by the Lot 1 contractor and the subsequent effect on NJR reporting systems and outputs.
c. The need of the Lot 2 contractor to be able to effectively analyse the data collected.
d. The effect of any changes on the data already held in the database and whether such changes would lead to a restriction in the size of the dataset available for analysis.
e. To ensure standard definitions of interventions and end points of interest are maintained across all of the MDS forms where at all possible.
f. The cost and administrative burden the changes would entail.
g. Scientific scrutiny of the impact of proposed changes to the MDS.
h. Any other factors that the group consider relevant.
MDSv8 is now moving into development and is expected to launch early in 2023. The key changes to the dataset are:
• Primary hip hemiarthroplasty will now be collected as part of the MDSv8. Conversions to a total hip replacement (THR) from a hemiarthroplasty will now be recorded on a H2 revision form
• A new form (RO) to capture ‘Reoperations other than revision’ will be introduced for non-revision operations involving joint replacements. These include fixation of periprosthetic fracture, manipulation under anaesthesia, soft tissue repairs and DAIR without modular exchange. Procedures where one or more components are added to, removed from or modified in a joint replacement will continue to be recorded on the relevant revision forms.
• Dual consultant operating will now be able to be recorded on all forms in cases where two consultants are operating together (as opposed to one assisting the other).
• Megaprothesis used in cancer or complex trauma surgery will now have a separate form for data capture.
• Focal knee replacements will now be recorded on knee primary (K1) forms and conversion from focal replacements to unicompartmental or total knee replacements will be recorded on knee revision (K2) forms.
• The complexity of hip and knee revision surgery will be captured on revision (H2 and K2 forms).
• Glenoid morphology will be collected as part of shoulder primary (S1) forms.
• A new field will be added to all forms to indicate that a procedure has been performed in the context of a clinical trial.
For more information about MDSv8, please see here.